In contrast, 8 weeks after MOG peptide administration, EAE mice displayed morphological abnormalities of myelin and axon (e.g., excess formation of myelin, detachment of myelin from axon) (Figure 4E,F), which are characteristic traits of demyelination previously described [23,37]. The gene discussed is MOG; the disease is Peripheral demyelination.